Related Experiment Videos
[Continuous ambulatory peritoneal dialysis. 5-year clinical experience]
Deutsche Medizinische Wochenschrift (1946)
|February 1, 1985
Summary
Continuous ambulatory peritoneal dialysis (CAPD) is a global treatment for chronic renal failure. A new connector system significantly reduced peritonitis rates, demonstrating CAPD
Area of Science:
- Nephrology
- Internal Medicine
Context:
- Continuous ambulatory peritoneal dialysis (CAPD) is a widely adopted treatment for chronic renal failure worldwide.
- Clinical experience with 34 CAPD patients over 642 treatment months (October 1978 - December 1983) is reported.
Purpose:
- To evaluate the clinical outcomes and challenges of Continuous ambulatory peritoneal dialysis (CAPD).
- To assess the impact of a new connector system on peritonitis rates in CAPD patients.
Summary:
- A new CAPD connector system introduced in 1983 reduced peritonitis incidence to 1 per 46 treatment months.
- CAPD was successfully continued in most patients, with only 7 discontinuing due to dialysis-related reasons.
- Key factors for successful CAPD include suitable materials, adequate space, trained personnel, and patient motivation.
Impact:
- CAPD offers a cost-effective alternative to home dialysis for well-selected and motivated patients.
- Patients meeting home dialysis criteria can achieve excellent rehabilitation through CAPD.
- Improvements in CAPD technology, like the new connector system, enhance treatment safety and efficacy.